Allen Jacob

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Renal Cell Carcinoma

Combination Therapy

Tyrosine Kinase

Top Venues

Proceedings (Baylor University. Medical Center)

Future oncology (London, England)

Expert review of anticancer therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Allen Jacob, Jaret Shook, Thomas Hutson
The implementation of lenvatinib/everolimus or lenvatinib/pembrolizumab combinations in the treatment of metastatic renal cell carcinoma. Expert review of anticancer therapy 21 (4) (2021)
Allen Jacob, Sujith Puskoor, Heath Douglas White
Bowel perforation in morbid obesity secondary to COVID-19 infection. Proceedings (Baylor University. Medical Center) 35 (2) (2021)
Allen Jacob, Jaret Shook, Thomas E Hutson
Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma. Future oncology (London, England) 16 (28) (2020)